Sign in
4

Changes in Ownership

Whitehawk Therapeutics, Inc. Filed Acc 0001209191-22-037893

Options or other derivatives

  • Director acquired 18,573 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Reeve Emma Director 2022-06-15 Grant or award · Stock Option (right to buy) +18,573 18,573 D: show line 1 in the form
Loading xslF345X03/doc4.xml…